Beth Israel Deaconess Medical Center
Boston, United States
Publications on this disease18
Research view
Switch to patient viewEndometrial cancer: who works on it
Groups that published on this disease or run trials on it, from public registries and publications. Researchers appear by name only once their profile is published.
Find fellow researchers
One card per institution. Pick a target or a country to narrow the list.
- All targets
- TP53 8
- PD-1 17
- HER2 13
- PTEN 3
- PI3K 7
- PD-L1 6
- mTOR 2
- AKT 2
- CTNNB1 1
- PIK3CA 6
- ARID1A 3
- BRCA1 2
- KRAS 5
- PARP 3
- VEGF 2
- CDK4/6 3
- ERK 0
- GLP-1 3
- STAT3 0
- TROP2 3
- BRCA2 1
- CTLA-4 2
- MAPK 0
- ESR1 0
- AR 0
- ATM 1
- AMPK 1
- AXL 2
- B7-H3 2
- COX-2 0
- FGFR 0
- IGF1R 0
- TIGIT 1
- BCL-2 0
- FTO 0
- GPX4 0
- HDAC 0
- HER3 1
- PALB2 1
- RAS 1
- BRAF 0
- EGFR 2
- EZH2 0
- JAK 0
- JNK 0
- KEAP1 1
- LAG-3 0
- MDM2 0
- MET 0
- MMP-9 0
- NLRP3 0
- PRAME 1
- PSMA 1
- SGLT2 1
- STING 0
- STK11 1
- APOE 0
- CD20 0
- CD47 0
- CDKN2A 0
UNC Lineberger Comprehensive Cancer Center
Chapel Hill, United States
Publications on this disease16
Angeles Alvarez Secord
Duke Medical Center · Durham, United States
Is this your team? Claim it
Latest publication · Int J Gynecol Cancer, Jun 2026Poly(adenosine diphosphate-ribose) polymerase inhibitor maintenance therapy with niraparib in patients with primary advanced or recurrent endometrial cancer receiving dostarlimab plus chemotherapy.
University of Oklahoma Health Sciences Center
Oklahoma City, United States
Publications on this disease13
Northwell Health
New Hyde Park, United States
Publications on this disease13
5 of 5+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.
Running research funding
Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.
European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-GF
Continuous Estrogen Monitoring Patch (EstroPatch)
The disease is named only in the funder's project summary, not in the title.
European Commission (Horizon Europe) · HORIZON-EIC-ACC
The disease is named only in the funder's project summary, not in the title.
2 of 2 running projects, newest first. Listed amounts together: €2.8m.
Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.
Who stopped a trial, and why
Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.
Suspended
“Funding and drug supply to continue the study are pending.”Registry text, quoted unchanged. Source
Trials that share participant data
Trials whose registry record says individual participant data (IPD) will be shared.
No trial in this view states that it shares participant data.
Search by method
Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.
- Single-Cell Analysis 8
- Organoids 3
- Mendelian Randomization Analysis 13
- CRISPR-Cas Systems 5
- Gene Expression Profiling 37
- Sequence Analysis, RNA 1
- Exome Sequencing 6
- Proteomics 17
- Metabolomics 7
- Mass Spectrometry 1
- Flow Cytometry 1
- Immunohistochemistry 85
- Liquid Biopsy 4
- Circulating Tumor DNA 9
- Xenograft Model Antitumor Assays 38
- Positron-Emission Tomography 4
- Magnetic Resonance Imaging 36
- Machine Learning 35
- Deep Learning 18
- Cohort Studies 82
- Genome-Wide Association Study 11
Paste an abstract
See which targets of this disease your abstract mentions, and go to the people working on them.
Matched in your browser only. The text is not sent, saved or logged.
Sources: ClinicalTrials.gov, EU CTR, OpenAlex, PubMed, NIH RePORTER, CORDIS. Machine-matched links are labelled.